Addition of Propranolol and Isosorbide Mononitrate to Endoscopic Variceal Ligation Does Not Reduce Variceal Rebleeding Incidence

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Kumar, Ashish ^a   Jha, Sanjeev Kumar ^b   Sharma, Praveen ^a   Dubey, Saroj ^b   Tyagi, Pankaj ^b   Sharma, Barjesh Chander ^b   Sarin, Shiv Kumar ^a,b  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ISOSORBIDE; PROPRANOLOL DERIVATIVE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BLEEDING; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPNEA; ENDOSCOPIC VARICEAL LIGATION; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEADACHE; HEMODYNAMICS; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; THORAX PAIN; TREATMENT FAILURE; VENOUS PRESSURE;

EID: 69249159574     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.049     Document Type: Article

References (29)

1. Jensen D.M. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122 (2002) 1620-1630
2. D'Amico G., De Franchis R., and Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
3. Carbonell N., Pauwels A., Serfaty L., et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40 (2004) 652-659
4. Graham D.Y., and Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 80 (1981) 800-809
5. Gonzalez R., Zamora J., Gomez-Camarero J., et al. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 149 (2008) 109-122
6. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
7. García-Pagán J.C., Feu F., Bosch J., et al. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 114 (1991) 869-873
8. Sarin S.K., and Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis 10 (2006) 627-651
9. Conn H.O. Ammonia tolerance in the diagnosis of esophageal varices. A comparison of endoscopic, radiologic, and biochemical techniques. J Lab Clin Med 70 (1967) 442-451
10. Groszmann R.J., and Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 39 (2004) 280-282
11. Garcia-Pagán J.C., Navasa M., Bosch J., et al. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 11 (1990) 230-238
12. Gournay J., Masliah C., Martin T., et al. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 31 (2000) 1239-1245
13. Garcia-Pagán J.C., and Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 526-535
14. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
15. Laine L., el-Newihi H.M., Migikovsky B., et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 119 (1993) 1-7
16. Gimson A.E., Ramage J.K., Panos M.Z., et al. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 342 (1993) 391-394
17. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 22 (1995) 466-471
18. Hou M.C., Lin H.C., Kuo B.I., et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology 21 (1995) 1517-1522
19. Lo G.H., and Lai K.H. The factors affecting risk of recurrent variceal bleeding. Gastroenterology 128 (2005) 244
20. Lo G.H. Prevention of esophageal variceal rebleeding. J Chin Med Assoc 69 (2006) 553-560
21. Harewood G.C., Baron T.H., and Song L.M. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding. J Gastroenterol Hepatol 21 (2006) 237-241
22. Bosch J., and García-Pagán J.C. Prevention of variceal rebleeding. Lancet 361 (2003) 952-954
23. Sharara A.I., and Rockey D.C. Gastroesophageal variceal hemorrhage. N Engl J Med 345 (2001) 669-681
24. Sarin S.K., Wadhawan M., Gupta R., et al. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci 50 (2005) 1538-1547
25. de la Peña J., Brullet E., Sanchez-Hernández E., et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41 (2005) 572-578
26. Lo G.H., Lai K.H., Cheng J.S., et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32 (2000) 461-465
27. Savoye G., Hochain P., Riachi G., et al. Early massive bleeding after endoscopic ligation for junctional varices. Endoscopy 30 (1998) S101
28. Bosch J. Prevention of variceal rebleeding: endoscopes, drugs, and more. Hepatology 32 (2000) 660-662
29. Mihas A.A., and Sanyal A.J. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 127 (2004) 621-629